Listing Details : LB-12796

Asking Price 20 Crs
Turnover 6.5 Crs
Legal Entity Private Limited
Category Trading Business
Sub Category Pharma Trading
Business Listed By Representative

Overview

- Established in 2014, company is a rapidly growing organization within the pharmaceutical industry. With an extensive portfolio spanning allopathic, ayurvedic, and nutraceutical segments. - Network of 20,000 doctors connected by 150 rep field force. - Top 5 brands are scaled across multiple states and have the potential to generate INR 100 Cr in sales in each. - A total of 27 brands in the portfolio and trademarks for all brands. - Top 4 brands have an average gross margin of 81% - Top 5 brands have 51% of total revenues. Long-term plans: - Build a brand that is based on trust and consistency. - Scale ethical product operations across 3 more states. - Take OTC brands to every corner of India.

Year of Establishment

2014

No. of Employees

100

Current Status of Business

Running

Business Relocatable

Yes

Property Type

Owned

Property Value

1 Crs

Property Classification

Industrial

Describe Property

The company has a rented office space in Mumbai (1,400 Sqft) and a warehouse space (2,000 Sqft) in the same building. It has purchased 3 domains and a D2C website with a cumulative visitor base of 15,000/month. The D2C website

Competition / Market

NA

Products & Services

Product Portfolio: 1. Cough Expectorant. 2. All in one cough Management. 3. Pain Management. 4. Indigestion reliever and appetite booster. And 23 More brands which all have Trademarks.

Growth Potential

Top 5 brands are scaled across multiple states and have the potential to generate INR 100 Cr in sales in each. - A total of 27 brands in the portfolio and trademarks for all brands. - Top 4 brands have an average gross margin of 81% - Top 5 brands have 51% of total revenues.

Reason For Sale

The decision to sell the company stems from a strategic consideration of succession planning. The next generation within the family is not prepared or willing to inherit and manage the business (Children now settled out of India). The sale presents an opportunity to ensure the company's continuity and sustained growth under new ownership that can further develop its potential and preserve its legacy.

Financial Details

EBITDA :- 32 Lacs
PAT :- 30 Lacs
Debt :- 3.5 Crs
Contact Business